Newsfiscal.ai
enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal Study
· Published
Article summary
enVVeno Medical announced its financial results for the third quarter of 2026 and provided an update on the upcoming TAVVE pivotal study for its enVVe system.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…